1. Home
  2. HALO vs FIVE Comparison

HALO vs FIVE Comparison

Compare HALO & FIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$108.28

Market Cap

11.2B

Sector

Health Care

ML Signal

HOLD

Logo Five Below Inc.

FIVE

Five Below Inc.

N/A

Current Price

$262.05

Market Cap

12.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
HALO
FIVE
Founded
1998
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
12.6B
IPO Year
2001
2012

Fundamental Metrics

Financial Performance
Metric
HALO
FIVE
Price
$108.28
$262.05
Analyst Decision
Buy
Buy
Analyst Count
11
20
Target Price
$78.64
$236.00
AVG Volume (30 Days)
2.3M
855.5K
Earning Date
05-05-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
40.65
EPS
3.11
2.21
Revenue
$151,862,000.00
$4,764,147,000.00
Revenue This Year
$28.24
$14.44
Revenue Next Year
$12.56
$9.37
P/E Ratio
$34.78
$113.23
Revenue Growth
N/A
22.90
52 Week Low
$61.23
$138.18
52 Week High
$108.49
$251.63

Technical Indicators

Market Signals
Indicator
HALO
FIVE
Relative Strength Index (RSI) 77.65 74.27
Support Level $67.12 $208.52
Resistance Level N/A N/A
Average True Range (ATR) 3.53 8.37
MACD 0.75 1.17
Stochastic Oscillator 97.08 99.49

Price Performance

Historical Comparison
HALO
FIVE

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About FIVE Five Below Inc.

Five Below Inc is a specialty value retailer offering a broad range of trend-right, high-quality products loved by the kid and the kid in all of customers. The Company's edited assortment of products includes select brands and licensed merchandise. The Company also sells its merchandise on the internet, through the Company's e-commerce website and mobile app, offering home delivery and the option to buy online and pick up in store. Additionally, the Company sells merchandise through on-demand third-party delivery services to enable its customers to shop online and receive convenient delivery. It derives revenue from sales of the Company's merchandise to customers.

Share on Social Networks: